Prevalence rate of diabetes mellitus and impaired fasting glycemia in hungary: Crosssectional study on nationally representative sample of people aged 20-69 years

Croatian Medical Journal

Volumn 51, Issue 2, 2010, Pages 151-156

  Jermendy, György ^a   Nádas, Judit ^a   Szigethy, Endre ^b   Széles, György ^b   Nagy, Attila ^b   Hídvégi, Tibor ^c   Paragh, György ^d   Ádány, Róza ^b  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c Petz Hospital   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HUNGARY; IMPAIRED FASTING GLYCEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HUNGARY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION;

EID: 77953796848     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2010.51.151     Document Type: Article

References (22)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7. Medline:11742409 doi:10.1038/414782a (Pubitemid 34000780)
2. Colagiuri S, Borch-Johnsen K, Glumer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetologia. 2005;48:1459-63. Medline:16007413 doi:10.1007/s00125-005-1843-y (Pubitemid 41175496)
3. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010;53:10-20. Medline:19890624 doi:10.1007/s00125-009-1573-1577.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. Medline:15111519 doi:10.2337/ diacare.27.5.1047
5. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-9. Medline:1516497 doi:10.2337/diacare.15.7.815
6. U .K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995;44:1249-58. Medline:7589820 doi:10.2337/diabetes.44.11.1249
7. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373:2215-21. Medline:19515410 doi:10.1016/ S0140-6736(09)60619-X
8. lberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451-63. Medline:17470191 doi:10.1111/j.1464-5491.2007.02157.x (Pubitemid 46669328)
9. International Diabetes Federation. Diabetes atlas. 3rd edition. Brussels: International Diabetes Federation; 2006.
10. International Diabetes Federation. Diabetes atlas. 4th edition. Brussels: International Diabetes Federation; 2009.
11. Szurkowska M, Szybinski Z, Nazim A, Szafraniec K, Jedrychowski W. Prevalence of type II diabetes mellitus in population of Krakow [in Polish]. Pol Arch Med Wewn. 2001;106:771-9. Medline:11928585
12. Lopatyński J, Mardarowicz G, Nicer T, Szczesniak G, Król H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland) [in Polish]. Pol Arch Med Wewn. 2001;106:781-6. Medline:11928586.
13. Szigethy E, Voko Z, Jermendy G, Nadas J, Paragh G, Blasko G, et al. The epidemiology of metabolic syndrome in the Hungarian adult population [abstract]. Diab Vasc Dis Res. 2007;4 Suppl 1:S94.
14. Szeles G, Voko Z, Jenei T, Kardos L, Pocsai Z, Bajtay A, et al. A preliminary evaluation of a health monitoring programme in Hungary. Eur J Public Health. 2005;15:26-32. Medline:15788800 doi:10.1093/eurpub/cki107
15. Verschuren WM. Serum cholesterol and coronary heart disease -a public health perspective. Neth J Med. 1997;51:1-9. Medline:9260484 doi:10.1016/S0300-2977(97)00019-3 (Pubitemid 27348826)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel II). JAMA 2001;285:2486-97. Medline:11368702 doi:10.1001/ jama.285.19.2486
17. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO consultation. Geneva (Switzerland): WHO; 2006.
18. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7. Medline:14578255 doi:10.2337/ diacare.26.11.3160
19. Borch-Johnsen K, Colagiuri S, Balkau B, Glumer C, Carstensen B, Ramachandran A, et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia. 2004;47:1396-402. Medline:15278279 doi:10.1007/ s00125-004-1468-1476
20. Metelko Z, Pavlic-Renar I, Poljicanin T, Szirovitza L, Turek S. Prevalence of diabetes mellitus in Croatia. Diabetes Res Clin Pract. 2008;81:263-7. Medline:18534707 doi:10.1016/ j.diabres.2008.04.016
21. Mokan M, Galajda P, Pridavkova D, Tomaskova V, Sutarik L, Krucinska L, et al. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Res Clin Pract. 2008;81:238-42. Medline:18495284 doi:10.1016/j.diabres. 2008.04.002
22. Wittek A, Sokalski B, Grzeszczak W, Strojek K. Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland. Exp Clin Endocrinol Diabetes. 2009;117:350-3. Medline:19536734 doi:10.1055/s-0029- 1220689.